Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis
- First Posted Date
- 2009-12-25
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Ore Pharmaceuticals, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT01039597
- Locations
- 🇨🇦
Robarts Research Institute, London, Ontario, Canada
🇮🇳Dr, Bhatnagar's Clinic, Ahmedabad, Gujarat, India
🇮🇳Vikram Jyoth Centre for Advanced Gastroenterology, Mysore, Karnataka, India
News
No news found